Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats
The chemical components of Xin'an famous prescription Ershen Zhenwu Decoction (ESZWD) are still unclear. The results showed that ESZWD could significantly reduce left ventricular end diastolic diameter, decrease N-terminal pro-brain natriuretic peptide (NT-proBNP), angiotensinII, aldosterone, r...
Main Authors: | Li-li Hong, Yan Zhao, Wei-dong Chen, Chen-yu Yang, Guo-zhuan Li, Hong-song Wang, Xiao-yu Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.913661/full |
Similar Items
-
Mechanisms of Zhenwu decoction for the treatment of renal fibrosis at various stages: What is the role of Corynebacterium?
by: Lijing Du, et al.
Published: (2022-09-01) -
Transcriptomic and metabolomic analysis of the effects of Zhenwu decoction on kidney yang deficiency pattern in chronic kidney disease
by: Pengfei Zheng, et al.
Published: (2023-04-01) -
Viewing the future research directions of heart failure from ge's phenotyping of heart failure with preserved ejection fraction
by: Yan-Xiang Zang, et al.
Published: (2021-01-01) -
Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1
by: Zhao Yang, et al.
Published: (2023-03-01) -
The Utility of Cognitive Screening in Asian Patients With Heart Failure: A Systematic Review
by: Qi Niu, et al.
Published: (2022-07-01)